In ER-positive breast cancer, GCs inhibited cell migration of several epithelial cancer types, including the MCF10A non-tumorigenic epithelial cell line and estrogen-receptor positive T47D breast cancer cells [188, 195, 196]. Here, ESR1 is linked to breast cancer.